Real-World 30-Day Outcomes for the SAPIEN 3 Ultra Resilia Transcatheter Heart Valve in the Treatment of Failed Bioprosthetic Mitral Valves: A Propensity-Matched Analysis

Authors

T Frisoli
M Eleid
A Krishnaswamy
S Kapadia
P Yadav
V Rajagopal
R Makkar
C Stinis
S Chetcuti
M Morse
A Frangieh
Amr Abbas, Corewell Health
B Whisenant
M Guerrero
E Rodriguez
G Ailawadi
W O'Neill

Document Type

Conference Proceeding

Publication Date

10-29-2024

Publication Title

Journal of the American College of Cardiology

Volume

84

Issue

18 Suppl

First Page

B234

Comments

36th Annual Symposium Transcatheter Cardiovascular Therapeutics (TCT), October 27-30, 2024, Washington, DC

Recommended Citation

Frisoli T, Eleid M, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, et al. [Abbas A]. Real-world 30 day outcomes for the SAPIEN 3 Ultra Resilia transcatheter heart valve in the treatment of failed bioprosthetic mitral valves: a propensity-matched analysis. J Am Coll Cardiol. 2024 Oct 29;84(18 Suppl):B234. doi:10.1016/j.jacc.2024.09.738

DOI

10.1016/j.jacc.2024.09.738